US based Boston Scientific has announced the signing of two strategic agreements to advance the company’s efforts to bring value based solutions aimed at improving outcomes and reducing the cost of cardiovascular care delivery to healthcare systems.
According to company press release, as part of an agreement with MedAxiom, a leading cardiovascular consulting company and nationally recognized community of progressive cardiovascular healthcare providers, Boston Scientific will offer programs to help improve the way care is delivered to patients suffering from cardiovascular conditions including heart failure, atrial fibrillation, structural heart and ischemic heart disease. These programs will assist hospitals and ambulatory care sites in developing and implementing comprehensive clinical and operational strategies to drive efficiencies across the care continuum, from diagnosis to treatment and ongoing care. This agreement brings together Boston Scientific’s strong expertise in lean practices, process improvement and supply chain optimization with MedAxiom’s deep experience in cardiovascular program leadership.
“We are focused on addressing the many challenges healthcare systems are facing, and expanding our offerings to solutions that leverage our organizational competencies and complement our differentiated technology platforms,” said Mike Mahoney, president and chief executive officer, Boston Scientific.
“Most hospital systems can benefit from the sharing of best practices – and methods to make this easier to do are welcome,” said David Hurrell, M.D., senior consulting cardiologist, Minneapolis Heart Institute, Allina Health System. “We are already seeing how our work with Boston Scientific can improve the quality and efficiencies of cardiovascular care.”